| Literature DB >> 25563077 |
Haritz Gurruchaga1, Laura Saenz del Burgo, Jesús Ciriza, Gorka Orive, Rosa María Hernández, Jose Luis Pedraz.
Abstract
INTRODUCTION: Cell encapsulation technology has improved enormously since it was proposed 50 years ago. The advantages offered over other alternative systems, such as the prevention of repetitive drug administration, have triggered the use of this technology in multiple therapeutic applications. AREAS COVERED: In this article, improvements in cell encapsulation technology and strategies to overcome the drawbacks that prevent its use in the clinic have been summarized and discussed. Different studies and clinical trials that have been performed in several therapeutic applications have also been described. EXPERT OPINION: The authors believe that the future translation of this technology from bench to bedside requires the optimization of diverse aspects: i) biosafety, controlling and monitoring cell viability; ii) biocompatibility, reducing pericapsular fibrotic growth and hypoxia suffered by the graft; iii) control over drug delivery; iv) and the final scale up. On the other hand, an area that deserves more attention is the cryopreservation of encapsulated cells as this will facilitate the arrival of these biosystems to the clinic.Entities:
Keywords: alginate; biocompatibility; biosafety; cell source; cryopreservation; drug delivery; microencapsulation; therapeutic applications
Mesh:
Year: 2015 PMID: 25563077 DOI: 10.1517/17425247.2015.1001362
Source DB: PubMed Journal: Expert Opin Drug Deliv ISSN: 1742-5247 Impact factor: 6.648